Compile Data Set for Download or QSAR
Report error Found 60 Enz. Inhib. hit(s) with all data for entry = 12120
Target5-hydroxytryptamine receptor 7(Human)
Centre National De La Recherche Scientifique

US Patent
LigandPNGBDBM681166(US20240199555, Reference 5-CT)
Affinity DataIC50: 0.0400nMAssay Description:The new compounds have been tested by radioligand binding competition activity at the human 5-HT1A (FAST-0500B), 5-HT2A (FAST-0505B), 5-HT2Cedited (F...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/24/2024
Entry Details
Go to US Patent

Target5-hydroxytryptamine receptor 7(Human)
Centre National De La Recherche Scientifique

US Patent
LigandPNGBDBM50253281(N-(4-Cyanophenylmethyl)-4-(2-diphenyl)-1-piperazin...)
Affinity DataIC50: 0.160nMAssay Description:The new compounds have been tested by radioligand binding competition activity at the human 5-HT1A (FAST-0500B), 5-HT2A (FAST-0505B), 5-HT2Cedited (F...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/24/2024
Entry Details
Go to US Patent

Target5-hydroxytryptamine receptor 7(Human)
Centre National De La Recherche Scientifique

US Patent
LigandPNGBDBM680902(US20240199555, Reference MOA51)
Affinity DataIC50: 0.290nMAssay Description:The new compounds have been tested by radioligand binding competition activity at the human 5-HT1A (FAST-0500B), 5-HT2A (FAST-0505B), 5-HT2Cedited (F...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/24/2024
Entry Details
Go to US Patent

Target5-hydroxytryptamine receptor 7(Human)
Centre National De La Recherche Scientifique

US Patent
LigandPNGBDBM680931(US20240199555, Reference JLB016)
Affinity DataIC50: 0.610nMAssay Description:The new compounds have been tested by radioligand binding competition activity at the human 5-HT1A (FAST-0500B), 5-HT2A (FAST-0505B), 5-HT2Cedited (F...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/24/2024
Entry Details
Go to US Patent

Target5-hydroxytryptamine receptor 7(Human)
Centre National De La Recherche Scientifique

US Patent
LigandPNGBDBM681157(US20240199555, Reference JLB060)
Affinity DataIC50: 0.980nMAssay Description:The new compounds have been tested by radioligand binding competition activity at the human 5-HT1A (FAST-0500B), 5-HT2A (FAST-0505B), 5-HT2Cedited (F...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/24/2024
Entry Details
Go to US Patent

Target5-hydroxytryptamine receptor 7(Human)
Centre National De La Recherche Scientifique

US Patent
LigandPNGBDBM680903(US20240199555, Reference Serodolin | US20240199555...)
Affinity DataIC50: 1.14nMAssay Description:The new compounds have been tested by radioligand binding competition activity at the human 5-HT1A (FAST-0500B), 5-HT2A (FAST-0505B), 5-HT2Cedited (F...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/24/2024
Entry Details
Go to US Patent

Target5-hydroxytryptamine receptor 7(Human)
Centre National De La Recherche Scientifique

US Patent
LigandPNGBDBM680945(US20240199555, Reference JLB018)
Affinity DataIC50: 1.22nMAssay Description:The new compounds have been tested by radioligand binding competition activity at the human 5-HT1A (FAST-0500B), 5-HT2A (FAST-0505B), 5-HT2Cedited (F...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/24/2024
Entry Details
Go to US Patent

Target5-hydroxytryptamine receptor 7(Human)
Centre National De La Recherche Scientifique

US Patent
LigandPNGBDBM680926(US20240199555, Reference JLB012)
Affinity DataIC50: 1.69nMAssay Description:The new compounds have been tested by radioligand binding competition activity at the human 5-HT1A (FAST-0500B), 5-HT2A (FAST-0505B), 5-HT2Cedited (F...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/24/2024
Entry Details
Go to US Patent

Target5-hydroxytryptamine receptor 7(Human)
Centre National De La Recherche Scientifique

US Patent
LigandPNGBDBM680908(US20240199555, Reference MOA43)
Affinity DataIC50: 1.95nMAssay Description:The new compounds have been tested by radioligand binding competition activity at the human 5-HT1A (FAST-0500B), 5-HT2A (FAST-0505B), 5-HT2Cedited (F...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/24/2024
Entry Details
Go to US Patent

Target5-hydroxytryptamine receptor 7(Human)
Centre National De La Recherche Scientifique

US Patent
LigandPNGBDBM50458526(CHEMBL4205349 | US20240199555, Reference E55888)
Affinity DataIC50: 2.68nMAssay Description:The new compounds have been tested by radioligand binding competition activity at the human 5-HT1A (FAST-0500B), 5-HT2A (FAST-0505B), 5-HT2Cedited (F...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/24/2024
Entry Details
Go to US Patent

Target5-hydroxytryptamine receptor 7(Human)
Centre National De La Recherche Scientifique

US Patent
LigandPNGBDBM681160(US20240199555, Reference JLB094)
Affinity DataIC50: 2.70nMAssay Description:The new compounds have been tested by radioligand binding competition activity at the human 5-HT1A (FAST-0500B), 5-HT2A (FAST-0505B), 5-HT2Cedited (F...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/24/2024
Entry Details
Go to US Patent

Target5-hydroxytryptamine receptor 7(Human)
Centre National De La Recherche Scientifique

US Patent
LigandPNGBDBM680928(US20240199555, Reference JLB014)
Affinity DataIC50: 3.29nMAssay Description:The new compounds have been tested by radioligand binding competition activity at the human 5-HT1A (FAST-0500B), 5-HT2A (FAST-0505B), 5-HT2Cedited (F...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/24/2024
Entry Details
Go to US Patent

Target5-hydroxytryptamine receptor 7(Human)
Centre National De La Recherche Scientifique

US Patent
LigandPNGBDBM50001884(8-Chloro-11-(4-methyl-piperazin-1-yl)-5H-dibenzo[b...)
Affinity DataIC50: 3.86nMAssay Description:The new compounds have been tested by radioligand binding competition activity at the human 5-HT1A (FAST-0500B), 5-HT2A (FAST-0505B), 5-HT2Cedited (F...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/24/2024
Entry Details
Go to US Patent

Target5-hydroxytryptamine receptor 7(Human)
Centre National De La Recherche Scientifique

US Patent
LigandPNGBDBM680903(US20240199555, Reference Serodolin | US20240199555...)
Affinity DataIC50: 4.39nMAssay Description:The new compounds have been tested by radioligand binding competition activity at the human 5-HT1A (FAST-0500B), 5-HT2A (FAST-0505B), 5-HT2Cedited (F...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/24/2024
Entry Details
Go to US Patent

Target5-hydroxytryptamine receptor 7(Human)
Centre National De La Recherche Scientifique

US Patent
LigandPNGBDBM680919(US20240199555, Reference JLB011)
Affinity DataIC50: 4.74nMAssay Description:The new compounds have been tested by radioligand binding competition activity at the human 5-HT1A (FAST-0500B), 5-HT2A (FAST-0505B), 5-HT2Cedited (F...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/24/2024
Entry Details
Go to US Patent

Target5-hydroxytryptamine receptor 7(Human)
Centre National De La Recherche Scientifique

US Patent
LigandPNGBDBM681158(US20240199555, Reference JLB061)
Affinity DataIC50: 5.97nMAssay Description:The new compounds have been tested by radioligand binding competition activity at the human 5-HT1A (FAST-0500B), 5-HT2A (FAST-0505B), 5-HT2Cedited (F...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/24/2024
Entry Details
Go to US Patent

Target5-hydroxytryptamine receptor 7(Human)
Centre National De La Recherche Scientifique

US Patent
LigandPNGBDBM680932(US20240199555, Reference JLB017)
Affinity DataIC50: 7.19nMAssay Description:The new compounds have been tested by radioligand binding competition activity at the human 5-HT1A (FAST-0500B), 5-HT2A (FAST-0505B), 5-HT2Cedited (F...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/24/2024
Entry Details
Go to US Patent

Target5-hydroxytryptamine receptor 7(Human)
Centre National De La Recherche Scientifique

US Patent
LigandPNGBDBM680909(US20240199555, Reference JLB010)
Affinity DataIC50: 7.99nMAssay Description:The new compounds have been tested by radioligand binding competition activity at the human 5-HT1A (FAST-0500B), 5-HT2A (FAST-0505B), 5-HT2Cedited (F...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/24/2024
Entry Details
Go to US Patent

Target5-hydroxytryptamine receptor 7(Human)
Centre National De La Recherche Scientifique

US Patent
LigandPNGBDBM680927(US20240199555, Reference JLB013)
Affinity DataIC50: 9.68nMAssay Description:The new compounds have been tested by radioligand binding competition activity at the human 5-HT1A (FAST-0500B), 5-HT2A (FAST-0505B), 5-HT2Cedited (F...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/24/2024
Entry Details
Go to US Patent

Target5-hydroxytryptamine receptor 7(Human)
Centre National De La Recherche Scientifique

US Patent
LigandPNGBDBM681161(US20240199555, Reference JLB102)
Affinity DataIC50: 17nMAssay Description:The new compounds have been tested by radioligand binding competition activity at the human 5-HT1A (FAST-0500B), 5-HT2A (FAST-0505B), 5-HT2Cedited (F...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/24/2024
Entry Details
Go to US Patent

Target5-hydroxytryptamine receptor 7(Human)
Centre National De La Recherche Scientifique

US Patent
LigandPNGBDBM680946(US20240199555, Reference JLB019)
Affinity DataIC50: 17.5nMAssay Description:The new compounds have been tested by radioligand binding competition activity at the human 5-HT1A (FAST-0500B), 5-HT2A (FAST-0505B), 5-HT2Cedited (F...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/24/2024
Entry Details
Go to US Patent

Target5-hydroxytryptamine receptor 7(Human)
Centre National De La Recherche Scientifique

US Patent
LigandPNGBDBM681054(US20240199555, Reference JLB048)
Affinity DataIC50: 19.1nMAssay Description:The new compounds have been tested by radioligand binding competition activity at the human 5-HT1A (FAST-0500B), 5-HT2A (FAST-0505B), 5-HT2Cedited (F...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/24/2024
Entry Details
Go to US Patent

Target5-hydroxytryptamine receptor 7(Human)
Centre National De La Recherche Scientifique

US Patent
LigandPNGBDBM681163(US20240199555, Reference JLB119)
Affinity DataIC50: 24.2nMAssay Description:The new compounds have been tested by radioligand binding competition activity at the human 5-HT1A (FAST-0500B), 5-HT2A (FAST-0505B), 5-HT2Cedited (F...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/24/2024
Entry Details
Go to US Patent

Target5-hydroxytryptamine receptor 7(Human)
Centre National De La Recherche Scientifique

US Patent
LigandPNGBDBM680963(US20240199555, Reference JLB021)
Affinity DataIC50: 31nMAssay Description:The new compounds have been tested by radioligand binding competition activity at the human 5-HT1A (FAST-0500B), 5-HT2A (FAST-0505B), 5-HT2Cedited (F...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/24/2024
Entry Details
Go to US Patent

Target5-hydroxytryptamine receptor 7(Human)
Centre National De La Recherche Scientifique

US Patent
LigandPNGBDBM681162(US20240199555, Reference JLB118)
Affinity DataIC50: 69.7nMAssay Description:The new compounds have been tested by radioligand binding competition activity at the human 5-HT1A (FAST-0500B), 5-HT2A (FAST-0505B), 5-HT2Cedited (F...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/24/2024
Entry Details
Go to US Patent

Target5-hydroxytryptamine receptor 7(Human)
Centre National De La Recherche Scientifique

US Patent
LigandPNGBDBM680980(US20240199555, Reference JLB022)
Affinity DataIC50: 136nMAssay Description:The new compounds have been tested by radioligand binding competition activity at the human 5-HT1A (FAST-0500B), 5-HT2A (FAST-0505B), 5-HT2Cedited (F...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/24/2024
Entry Details
Go to US Patent

Target5-hydroxytryptamine receptor 7(Human)
Centre National De La Recherche Scientifique

US Patent
LigandPNGBDBM681159(US20240199555, Reference JLB088)
Affinity DataIC50: 174nMAssay Description:The new compounds have been tested by radioligand binding competition activity at the human 5-HT1A (FAST-0500B), 5-HT2A (FAST-0505B), 5-HT2Cedited (F...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/24/2024
Entry Details
Go to US Patent

Target5-hydroxytryptamine receptor 7(Human)
Centre National De La Recherche Scientifique

US Patent
LigandPNGBDBM680953(US20240199555, Reference JLB020)
Affinity DataIC50: 260nMAssay Description:The new compounds have been tested by radioligand binding competition activity at the human 5-HT1A (FAST-0500B), 5-HT2A (FAST-0505B), 5-HT2Cedited (F...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/24/2024
Entry Details
Go to US Patent

Target5-hydroxytryptamine receptor 7(Human)
Centre National De La Recherche Scientifique

US Patent
LigandPNGBDBM680991(US20240199555, Reference JLB023)
Affinity DataIC50: 370nMAssay Description:The new compounds have been tested by radioligand binding competition activity at the human 5-HT1A (FAST-0500B), 5-HT2A (FAST-0505B), 5-HT2Cedited (F...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/24/2024
Entry Details
Go to US Patent

Target5-hydroxytryptamine receptor 7(Human)
Centre National De La Recherche Scientifique

US Patent
LigandPNGBDBM681164(US20240199555, Reference JLB138)
Affinity DataIC50: 5.07E+3nMAssay Description:The new compounds have been tested by radioligand binding competition activity at the human 5-HT1A (FAST-0500B), 5-HT2A (FAST-0505B), 5-HT2Cedited (F...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/24/2024
Entry Details
Go to US Patent

Target5-hydroxytryptamine receptor 7(Human)
Centre National De La Recherche Scientifique

US Patent
LigandPNGBDBM681166(US20240199555, Reference 5-CT)
Affinity DataKi:  0.0300nMAssay Description:The new compounds have been tested by radioligand binding competition activity at the human 5-HT1A (FAST-0500B), 5-HT2A (FAST-0505B), 5-HT2Cedited (F...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/24/2024
Entry Details
Go to US Patent

Target5-hydroxytryptamine receptor 7(Human)
Centre National De La Recherche Scientifique

US Patent
LigandPNGBDBM50253281(N-(4-Cyanophenylmethyl)-4-(2-diphenyl)-1-piperazin...)
Affinity DataKi:  0.110nMAssay Description:The new compounds have been tested by radioligand binding competition activity at the human 5-HT1A (FAST-0500B), 5-HT2A (FAST-0505B), 5-HT2Cedited (F...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/24/2024
Entry Details
Go to US Patent

Target5-hydroxytryptamine receptor 7(Human)
Centre National De La Recherche Scientifique

US Patent
LigandPNGBDBM680902(US20240199555, Reference MOA51)
Affinity DataKi:  0.200nMAssay Description:The new compounds have been tested by radioligand binding competition activity at the human 5-HT1A (FAST-0500B), 5-HT2A (FAST-0505B), 5-HT2Cedited (F...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/24/2024
Entry Details
Go to US Patent

Target5-hydroxytryptamine receptor 7(Human)
Centre National De La Recherche Scientifique

US Patent
LigandPNGBDBM680931(US20240199555, Reference JLB016)
Affinity DataKi:  0.430nMAssay Description:The new compounds have been tested by radioligand binding competition activity at the human 5-HT1A (FAST-0500B), 5-HT2A (FAST-0505B), 5-HT2Cedited (F...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/24/2024
Entry Details
Go to US Patent

Target5-hydroxytryptamine receptor 7(Human)
Centre National De La Recherche Scientifique

US Patent
LigandPNGBDBM681157(US20240199555, Reference JLB060)
Affinity DataKi:  0.690nMAssay Description:The new compounds have been tested by radioligand binding competition activity at the human 5-HT1A (FAST-0500B), 5-HT2A (FAST-0505B), 5-HT2Cedited (F...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/24/2024
Entry Details
Go to US Patent

Target5-hydroxytryptamine receptor 7(Human)
Centre National De La Recherche Scientifique

US Patent
LigandPNGBDBM680903(US20240199555, Reference Serodolin | US20240199555...)
Affinity DataKi:  0.800nMAssay Description:The new compounds have been tested by radioligand binding competition activity at the human 5-HT1A (FAST-0500B), 5-HT2A (FAST-0505B), 5-HT2Cedited (F...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/24/2024
Entry Details
Go to US Patent

Target5-hydroxytryptamine receptor 7(Human)
Centre National De La Recherche Scientifique

US Patent
LigandPNGBDBM680945(US20240199555, Reference JLB018)
Affinity DataKi:  0.860nMAssay Description:The new compounds have been tested by radioligand binding competition activity at the human 5-HT1A (FAST-0500B), 5-HT2A (FAST-0505B), 5-HT2Cedited (F...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/24/2024
Entry Details
Go to US Patent

Target5-hydroxytryptamine receptor 7(Human)
Centre National De La Recherche Scientifique

US Patent
LigandPNGBDBM680926(US20240199555, Reference JLB012)
Affinity DataKi:  1.18nMAssay Description:The new compounds have been tested by radioligand binding competition activity at the human 5-HT1A (FAST-0500B), 5-HT2A (FAST-0505B), 5-HT2Cedited (F...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/24/2024
Entry Details
Go to US Patent

Target5-hydroxytryptamine receptor 7(Human)
Centre National De La Recherche Scientifique

US Patent
LigandPNGBDBM680908(US20240199555, Reference MOA43)
Affinity DataKi:  1.37nMAssay Description:The new compounds have been tested by radioligand binding competition activity at the human 5-HT1A (FAST-0500B), 5-HT2A (FAST-0505B), 5-HT2Cedited (F...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/24/2024
Entry Details
Go to US Patent

Target5-hydroxytryptamine receptor 7(Human)
Centre National De La Recherche Scientifique

US Patent
LigandPNGBDBM50458526(CHEMBL4205349 | US20240199555, Reference E55888)
Affinity DataKi:  1.88nMAssay Description:The new compounds have been tested by radioligand binding competition activity at the human 5-HT1A (FAST-0500B), 5-HT2A (FAST-0505B), 5-HT2Cedited (F...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/24/2024
Entry Details
Go to US Patent

Target5-hydroxytryptamine receptor 7(Human)
Centre National De La Recherche Scientifique

US Patent
LigandPNGBDBM681160(US20240199555, Reference JLB094)
Affinity DataKi:  1.90nMAssay Description:The new compounds have been tested by radioligand binding competition activity at the human 5-HT1A (FAST-0500B), 5-HT2A (FAST-0505B), 5-HT2Cedited (F...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/24/2024
Entry Details
Go to US Patent

Target5-hydroxytryptamine receptor 7(Human)
Centre National De La Recherche Scientifique

US Patent
LigandPNGBDBM680928(US20240199555, Reference JLB014)
Affinity DataKi:  2.31nMAssay Description:The new compounds have been tested by radioligand binding competition activity at the human 5-HT1A (FAST-0500B), 5-HT2A (FAST-0505B), 5-HT2Cedited (F...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/24/2024
Entry Details
Go to US Patent

Target5-hydroxytryptamine receptor 7(Human)
Centre National De La Recherche Scientifique

US Patent
LigandPNGBDBM50001884(8-Chloro-11-(4-methyl-piperazin-1-yl)-5H-dibenzo[b...)
Affinity DataKi:  2.71nMAssay Description:The new compounds have been tested by radioligand binding competition activity at the human 5-HT1A (FAST-0500B), 5-HT2A (FAST-0505B), 5-HT2Cedited (F...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/24/2024
Entry Details
Go to US Patent

Target5-hydroxytryptamine receptor 7(Human)
Centre National De La Recherche Scientifique

US Patent
LigandPNGBDBM680903(US20240199555, Reference Serodolin | US20240199555...)
Affinity DataKi:  3.09nMAssay Description:The new compounds have been tested by radioligand binding competition activity at the human 5-HT1A (FAST-0500B), 5-HT2A (FAST-0505B), 5-HT2Cedited (F...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/24/2024
Entry Details
Go to US Patent

Target5-hydroxytryptamine receptor 7(Human)
Centre National De La Recherche Scientifique

US Patent
LigandPNGBDBM680919(US20240199555, Reference JLB011)
Affinity DataKi:  3.33nMAssay Description:The new compounds have been tested by radioligand binding competition activity at the human 5-HT1A (FAST-0500B), 5-HT2A (FAST-0505B), 5-HT2Cedited (F...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/24/2024
Entry Details
Go to US Patent

Target5-hydroxytryptamine receptor 7(Human)
Centre National De La Recherche Scientifique

US Patent
LigandPNGBDBM681158(US20240199555, Reference JLB061)
Affinity DataKi:  4.19nMAssay Description:The new compounds have been tested by radioligand binding competition activity at the human 5-HT1A (FAST-0500B), 5-HT2A (FAST-0505B), 5-HT2Cedited (F...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/24/2024
Entry Details
Go to US Patent

Target5-hydroxytryptamine receptor 7(Human)
Centre National De La Recherche Scientifique

US Patent
LigandPNGBDBM680932(US20240199555, Reference JLB017)
Affinity DataKi:  5.05nMAssay Description:The new compounds have been tested by radioligand binding competition activity at the human 5-HT1A (FAST-0500B), 5-HT2A (FAST-0505B), 5-HT2Cedited (F...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/24/2024
Entry Details
Go to US Patent

Target5-hydroxytryptamine receptor 7(Human)
Centre National De La Recherche Scientifique

US Patent
LigandPNGBDBM680909(US20240199555, Reference JLB010)
Affinity DataKi:  5.61nMAssay Description:The new compounds have been tested by radioligand binding competition activity at the human 5-HT1A (FAST-0500B), 5-HT2A (FAST-0505B), 5-HT2Cedited (F...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/24/2024
Entry Details
Go to US Patent

Target5-hydroxytryptamine receptor 7(Human)
Centre National De La Recherche Scientifique

US Patent
LigandPNGBDBM680927(US20240199555, Reference JLB013)
Affinity DataKi:  6.80nMAssay Description:The new compounds have been tested by radioligand binding competition activity at the human 5-HT1A (FAST-0500B), 5-HT2A (FAST-0505B), 5-HT2Cedited (F...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/24/2024
Entry Details
Go to US Patent

Target5-hydroxytryptamine receptor 7(Human)
Centre National De La Recherche Scientifique

US Patent
LigandPNGBDBM681161(US20240199555, Reference JLB102)
Affinity DataKi:  11.9nMAssay Description:The new compounds have been tested by radioligand binding competition activity at the human 5-HT1A (FAST-0500B), 5-HT2A (FAST-0505B), 5-HT2Cedited (F...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/24/2024
Entry Details
Go to US Patent

Displayed 1 to 50 (of 60 total ) | Next | Last >>
Jump to: